Seguir
M. R. Yadav
M. R. Yadav
Director (R & D), Research and Development Cell, Parul University, Waghodia Road, Vadodara-391760
Dirección de correo verificada de paruluniversity.ac.in
Título
Citado por
Citado por
Año
Current perspective of TACE inhibitors: a review
S DasGupta, PR Murumkar, R Giridhar, MR Yadav
Bioorganic & medicinal chemistry 17 (2), 444-459, 2009
1382009
Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists—A perspective
P Naik, P Murumkar, R Giridhar, MR Yadav
Bioorganic & medicinal chemistry 18 (24), 8418-8456, 2010
1322010
Prodrug designing of NSAIDs
PK Halen, PR Murumkar, R Giridhar, MR Yadav
Mini reviews in medicinal chemistry 9 (1), 124-139, 2009
1302009
Recent advances in selective α1-adrenoreceptor antagonists as antihypertensive agents
KS Jain, JB Bariwal, MK Kathiravan, MS Phoujdar, RS Sahne, ...
Bioorganic & medicinal chemistry 16 (9), 4759-4800, 2008
1252008
Overview of the development of DprE1 inhibitors for combating the menace of tuberculosis
RV Chikhale, MA Barmade, PR Murumkar, MR Yadav
Journal of medicinal chemistry 61 (19), 8563-8593, 2018
1122018
Benzylpiperidine-linked diarylthiazoles as potential anti-Alzheimer’s agents: synthesis and biological evaluation
M Shidore, J Machhi, K Shingala, P Murumkar, MK Sharma, N Agrawal, ...
Journal of medicinal chemistry 59 (12), 5823-5846, 2016
1002016
Medicinal chemistry perspective of fused isoxazole derivatives
M A Barmade, P R Murumkar, M Kumar Sharma, M Ram Yadav
Current Topics in Medicinal Chemistry 16 (26), 2863-2883, 2016
942016
The search for potent, small molecule NNRTIs: A review
DG Prajapati, R Ramajayam, MR Yadav, R Giridhar
Bioorganic & medicinal chemistry 17 (16), 5744-5762, 2009
902009
AntiHIV, Antibacterial and Antifungal Activities of Some Novel 1, 4-disubstituted-1, 2, 4-triazolo [4, 3-a] quinazolin-5 (4H)-ones.
V Alagarsamy, R Giridhar, MR Yadav, R Revathi, K Ruckmani, ...
Indian Journal of Pharmaceutical Sciences 68 (4), 2006
822006
Bismuth-norfloxacin complex: Synthesis, physicochemical and antimicrobial evaluation
AR Shaikh, R Giridhar, MR Yadav
International journal of pharmaceutics 332 (1-2), 24-30, 2007
802007
Chemical and pharmacological studies on fixed oil of Ocimum sanctum.
S Singh, DK Majumdar, MR Yadav
Indian journal of experimental biology 34 (12), 1212-1215, 1996
771996
Prospective therapeutic agents for obesity: molecular modification approaches of centrally and peripherally acting selective cannabinoid 1 receptor antagonists
MK Sharma, PR Murumkar, AM Kanhed, R Giridhar, MR Yadav
European journal of medicinal chemistry 79, 298-339, 2014
742014
Developing steroidal aromatase inhibitors-an effective armament to win the battle against breast cancer
MR Yadav, MA Barmade, RS Tamboli, PR Murumkar
European journal of medicinal chemistry 105, 1-38, 2015
662015
Identification of potential Mpro inhibitors for the treatment of COVID-19 by using systematic virtual screening approach
AM Kanhed, DV Patel, DM Teli, NR Patel, MT Chhabria, MR Yadav
Molecular diversity 25, 383-401, 2021
652021
5 Heterosteroids and drug research
H Singh, DP Jindal, MR Yadav, M Kumar
Progress in medicinal chemistry 28, 233-300, 1991
621991
Novel TACE inhibitors in drug discovery: a review of patented compounds
PR Murumkar, S DasGupta, SR Chandani, R Giridhar, MR Yadav
Expert opinion on therapeutic patents 20 (1), 31-57, 2010
602010
Synthesis and anti-inflammatory activity of 2, 3-diaryl-4 (3H)-quinazolinones
MR Yadav, ST Shirude, A Parmar, R Balaraman, R Giridhar
Chemistry of heterocyclic compounds 42, 1038-1045, 2006
602006
Effect of bis [curcumino] oxovanadium complex on non-diabetic and streptozotocin-induced diabetic rats
JB Majithiya, R Balaraman, R Giridhar, MR Yadav
Journal of Trace Elements in Medicine and Biology 18 (3), 211-217, 2005
582005
Synthesis and pharmacological investigation of novel 1-substituted-4-phenyl-1, 2, 4-triazolo [4, 3-a] quinazolin-5 (4H)-ones as a new class of H1-antihistaminic agents
V Alagarsamy, R Giridhar, MR Yadav
Bioorganic & Medicinal Chemistry Letters 15 (7), 1877-1880, 2005
552005
Development of predictive pharmacophore model for in silico screening, and 3D QSAR CoMFA and CoMSIA studies for lead optimization, for designing of potent tumor necrosis factor …
PR Murumkar, VP Zambre, MR Yadav
Journal of computer-aided molecular design 24, 143-156, 2010
522010
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20